CXADR and neoplasm: In the current work, it is important to note that we found no evidence from cell cycle gene expression of significant hepatocyte proliferation with CITCO treatment, nor did we find increased liver weight or liver:body weight ratios at the conclusion of the carcinogenicity study despite half of the hCAR/hPXR group developing tumours (Fig. 5B).